Suppr超能文献

相似文献

1
Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.
Clin Cancer Res. 2011 Nov 1;17(21):6658-70. doi: 10.1158/1078-0432.CCR-11-0046. Epub 2011 Sep 8.
2
TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
Clin Cancer Res. 2012 Jan 1;18(1):290-300. doi: 10.1158/1078-0432.CCR-11-2260. Epub 2011 Nov 16.
3
TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
N Engl J Med. 2007 Dec 20;357(25):2552-61. doi: 10.1056/NEJMoa073770.
6
TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Laryngoscope. 2014 Jul;124(7):E267-73. doi: 10.1002/lary.24595. Epub 2014 Feb 20.
10
TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
J Cell Biochem. 2016 Dec;117(12):2682-2692. doi: 10.1002/jcb.25592. Epub 2016 Jun 3.

引用本文的文献

1
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers.
Cell Mol Biol Lett. 2025 Jun 14;30(1):68. doi: 10.1186/s11658-025-00751-5.
2
CircTP53/USP10/p53 signaling Axis as a Novel Regulator of Progression and Prognosis of Head and Neck Squamous Cell Carcinoma.
Adv Sci (Weinh). 2025 Aug;12(30):e14961. doi: 10.1002/advs.202414961. Epub 2025 Jun 4.
5
Characterization of a Diverse Set of Conditionally Reprogrammed Head and Neck Cancer Cell Cultures.
Laryngoscope. 2024 Jun;134(6):2748-2756. doi: 10.1002/lary.31236. Epub 2024 Jan 30.
6
Ethanol induces replication fork stalling and membrane stress in immortalized laryngeal cells.
iScience. 2023 Nov 23;26(12):108564. doi: 10.1016/j.isci.2023.108564. eCollection 2023 Dec 15.
8
Metal-Based Anticancer Complexes and p53: How Much Do We Know?
Cancers (Basel). 2023 May 19;15(10):2834. doi: 10.3390/cancers15102834.
9
Molecular risk factors for locoregional recurrence in resected non-small cell lung cancer.
Cancer Med. 2023 Jul;12(14):15026-15036. doi: 10.1002/cam4.6165. Epub 2023 May 29.

本文引用的文献

1
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.
Clin Cancer Res. 2011 Dec 1;17(23):7248-64. doi: 10.1158/1078-0432.CCR-11-0690. Epub 2011 Aug 25.
2
Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.
Clin Cancer Res. 2011 Jun 1;17(11):3733-41. doi: 10.1158/1078-0432.CCR-11-0183. Epub 2011 Apr 5.
3
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
5
Cancer statistics, 2010.
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
6
Human papillomavirus and survival of patients with oropharyngeal cancer.
N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.
8
Xenograft models of head and neck cancers.
Head Neck Oncol. 2009 Aug 13;1:32. doi: 10.1186/1758-3284-1-32.
9
Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma.
Br J Cancer. 2008 Nov 18;99(10):1684-94. doi: 10.1038/sj.bjc.6604735. Epub 2008 Oct 28.
10
Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination.
Cancer Biol Ther. 2008 May;7(5):699-708. doi: 10.4161/cbt.7.5.5712. Epub 2008 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验